APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 35 filers reported holding APREA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $61,358 | -49.3% | 185,371 | -0.2% | 0.00% | – |
| Q3 2022 | $121,000 | -13.6% | 185,741 | -0.6% | 0.00% | – |
| Q2 2022 | $140,000 | -67.3% | 186,779 | -18.8% | 0.00% | – |
| Q1 2022 | $428,000 | -35.8% | 230,165 | -0.9% | 0.00% | – |
| Q4 2021 | $667,000 | -63.2% | 232,211 | -34.5% | 0.00% | – |
| Q3 2021 | $1,811,000 | +3.8% | 354,275 | -0.9% | 0.00% | – |
| Q2 2021 | $1,744,000 | -57.8% | 357,611 | -55.9% | 0.00% | – |
| Q1 2021 | $4,135,000 | +1.4% | 810,852 | -2.1% | 0.00% | – |
| Q4 2020 | $4,078,000 | -65.3% | 828,568 | +69.6% | 0.00% | – |
| Q3 2020 | $11,753,000 | -36.8% | 488,488 | +1.9% | 0.00% | -100.0% |
| Q2 2020 | $18,595,000 | +50.5% | 479,500 | +34.8% | 0.00% | 0.0% |
| Q1 2020 | $12,359,000 | -21.7% | 355,583 | +3.4% | 0.00% | 0.0% |
| Q4 2019 | $15,785,000 | – | 343,967 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Princeton Global Asset Management LLC | 100 | $444 | 0.00% |
| Quent Capital, LLC | 3 | $13 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |